Search
Search Results
##search.searchResults.foundPlural##
-
Treating relapsed/refractory acute myeloid leukemia with chidamide, fludarabine, cytarabine and granulocyte-colony stimulating factor with subsequent bridging to myeloablative allogeneic hematopoietic stem cell transplantation Treating relapsed/refractory acute myeloid leukemia with chidamide, fludarabine, cytarabine and G-CSF
1889PDF: 636HTML: 368 -
GILTERITINIB (XOSPATA ®) IN TURKEY: EARLY ACCESS PROGRAM RESULTS Gilteritinib (XOSPATA ®) in Turkey
1583PDF: 968Suppl. Files: 489HTML: 303 -
THE IMPORTANCE OF TARGETED NEXT-GENERATION SEQUENCING USAGE IN CYTOGENETICALLY NORMAL MYELOID MALIGNANCIES Targeted next-generation sequencing usage in cytogenetically normal myeloid malignancies
2391PDF: 630HTML: 377 -
INVASIVE FUNGAL INFECTION IN CHILDREN WITH ACUTE LEUKEMIA AND SEVERE APLASTIC ANEMIA IFI in Children with Acute Leukemia and SAA
2922PDF: 977HTML: 308 -
-
Acute Panmyelosis with Myelofibrosis - A Rare Subtype of Acute Myeloid Leukemia
3456PDF: 1033HTML: 3178flowcytometric result of peripheral blood sample: 239 -
THERAPY-RELATED MYELOID MALIGNANCIES IN MYELOMA
2600PDF: 850HTML: 1750 -
MANAGEMENT OF ACUTE PROMYELOCYTIC LEUKEMIA IN THE ELDERLY
2887PDF: 1228HTML: 3321 -
Pseudo-differentiation syndrome
1501PDF: 720HTML: 10887Figure 1: peripheral blood showing myeloblasts with auer rods: 155Figure 2: CXR upon presentation to the hospital- no infiltrates nor consolidation changes: 140Figure 3: CXR showing pulmonary infiltartes with consolidation: 163Figure 4: CXR after starting steroid therapy- where the infiltrates have melted away: 146Figure 5: barograph showing the rising TLC ad ANC values- associated with worsening symptoms and increasing pulmonary infiltrates in CXR: 141 -
MOLECULAR PATHOGENESIS OF SECONDARY ACUTE PROMYELOCYTIC LEUKEMIA
3191PDF: 937HTML: 6619Untitled: 280Untitled: 239Untitled: 257Untitled: 263 -
RECENT ADVANCES IN THE 5Q- SYNDROME
3085PDF: 1922HTML: 3830Pellagatti Fig 1: 264Pellagatti Fig. 2: 251 -
BONE MARROW MICROENVIRONMENT INVOLVEMENT IN T-MN: FOCUS ON MESENCHYMAL STEM CELLS MESENCHYMAL STEM CELL IN T-MN
1991PDF: 1078HTML: 254 -
SUSTAINED REMISSION IN AN ELDERLY PATIENT WITH ACUTE MYELOID LEUKEMIA FOLLOWING GILTERITINIB TREATMENT AS THIRD-LINE SALVAGE THERAPY Long-lasting disease remission with third line therapy with gilteritinib
1063PDF: 568HTML: 341 -
Sorafenib induced Hand Foot Skin Rash in FLT3 ITD mutated Acute Myeloid leukemia- A case report and review of literature
2124PDF: 1008HTML: 1783Sorafenib induced Hand Foot Skin Rash in FLT3 ITD mutated AML- IMAGES: 210 -
THERAPY-RELATED MYELOID NEOPLASMS: CONSIDERATIONS FOR PATIENTS’ CLINICAL EVALUATION. Clinical Evaluation of T-AML
2205PDF: 889HTML: 266 -
Complex and Multifaceted Therapy-Related Myeloid Neoplasm Following Laryngeal Cancer Treated with Cisplatin and Radiotherapy
1264PDF: 807HTML: 1535Figure 1: 245Figure 2: 245 -
miR-155-5p PROMOTES CD34+ APOPTOSIS AND INHIBITS BONE MARROW HEMATOPOIESIS IN MYELODYSPLASTIC SYNDROMES BY RAC1/CREB/MIR-15B AXIS
843PDF: 944PDF Supp. Files: 107HTML: 262 -
Magnusiomyces capitatus Breakthrough Infection in Allogeneic Hematopoietic Cell Transplant Recipients Receiving Echinocandin Prophylaxis: Clinical Features, Management, and Review of the Literature
96PDF: 156Suppl. Files: 20Html: 105Html Suppl. Files: 80 -
ANORECTAL PATHOLOGIES IN THE COURSE OF ACUTE LEUKAEMIAS: PREDICTIVE PARAMETERS Anorectal pathologies in leukemias
1299PDF: 794Html: 122 -
HEMATOPOIETIC CELL TRANSPLANTATION FOR OLDER PATIENTS WITH MDS
2204PDF: 835HTML: 3275 -
Tacrolimus Associated Posterior Reversible Encephalopathy Syndrome – A Case Series and Review
3716PDF: 1621HTML: 4519CoverLetter: 236Figure1: 248







